Hartwig Huland

发表

Systematic biopsies and digital rectal examination to identify the nerve-sparing side for radical prostatectomy without risk of positive margin in patients with clinical stage T2, N0 prostatic carcinoma.

H. Huland, R. Henke, D. Hübner, 1994, Urology.

Diagnosis of renal transplant rejection

H. Huland, P. Hammerer, R. Arndt, 1988, World Journal of Urology.

Subjective and objective prospective, long-term analysis of quality of life during inhaled interleukin-2 immunotherapy.

H. Heinzer, H. Huland, T. Mir, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation and Genomic Instability in Prostate Cancer Statement of Translational Relevance

T. Schlomm, S. Steurer, C. Wittmer, 2022 .

Prostate cancer detection and dutasteride: utility and limitations of prostate-specific antigen in men with previous negative biopsies.

J. Barentsz, T. Hambrock, P. V. van Leeuwen, 2011, European urology.

Adherence of the indication to European Association of Urology guideline recommended pelvic lymph node dissection at a high-volume center: Differences between open and robot-assisted radical prostatectomy.

A. Haese*, T. Schlomm, H. Heinzer, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Influence of low-molecular-weight heparin dosage on red blood cell transfusion, lymphocele rate and drainage duration after open radical prostatectomy.

T. Schlomm, H. Heinzer, M. Graefen, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Pyelonephritic scarring in 213 patients with upper and lower urinary tract infections: long-term followup.

H. Huland, R. Busch, Hartwig Huland, 1984, The Journal of urology.

Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.

M. Graefen, J. Noldus, P. Hammerer, 1999, The Journal of urology.

Chronic pyelonephritis as a cause of end stage renal disease.

H. Huland, R. Busch, Hartwig Huland, 1982, The Journal of urology.

Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomy.

A. Haese*, M. Graefen, U. Michl, 1998, Urology.

Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.

A. Haese*, H. Lilja, M. Graefen, 2000, The Journal of urology.

Partin Tables cannot accurately predict the pathological stage at radical prostatectomy.

U. Capitanio, F. Montorsi, T. Schlomm, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomy

T. Schlomm, S. Steurer, S. Minner, 2013, Prostate Cancer and Prostatic Diseases.

Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer

T. Schlomm, R. Simon, H. Huland, 2018, Scientific Reports.

The role of C-reactive protein in graft dysfunction after renal transplantation.

H. Huland, S. Conrad, C. Reek, 1999, The Journal of urology.